acn/arsn for personal use only lagoda investment management, l.p., lagoda investment management,...
TRANSCRIPT
604 page 1/2 15 July 2001
36709164_1_FORM 604 - CLINUVEL PHARMACEUTICALS LIMITED - OVER 10%.DOCX
Form 604 Corporations Act 2001
Section 671B
Notice of change of interests of substantial holder
To Company Name/Scheme Clinuvel Pharmaceuticals Limited
ACN/ARSN ACN 089 644 119
1. Details of substantial holder (1)
Name
Lagoda Investment Management, L.P., Lagoda Investment Management, LLC, Fatima Dickey and Richard Bayles. This Form 604 is filed by Lagoda Investment Management, LLC on behalf of it, Lagoda Investment Management, L.P., Fatima Dickey and Richard Bayles.
ACN/ARSN (if applicable) n/a There was a change in the interests of the substantial holder on 07/04/2016 The previous notice was given to the company on 15/03/2016 The previous notice was dated 11/03/2016
2. Previous and present voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:
Class of securities (4)
Previous notice Present notice
Person’s votes Voting power (5) Person’s votes
Voting power (5) (Based on 47,080,637 shares on issue in total)
Ordinary Shares 4,625,668 9.83% 4,720,236 10.03%
3. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows: or
Date of change
Person whose relevant interest changed
Nature of change (6)
Consideration given in relation to change (7)
Class and number of securities affected
Person’s votes affected
N/A
Lagoda Investment Management, L.P., Lagoda Investment Management, LLC, Fatima Dickey and Richard Bayles
Correction from overstatement in previous filing on 15/03/2016
$2.92 per share 21,200 Ordinary Shares
-0.04503%
17 March 2016 See row 1 above Acquisition on market by Fiduciary Trust
$3.51 per share 11,443 Ordinary Shares 0.02431%
18 March 2016 See row 1 above Acquisition on market by Fiduciary Trust
$3.50. per share 13,525 Ordinary Shares 0.02873%
18 March 2016 See row 1 above Acquisition on market by U.S. Trust
$3.50 per share 2,000 Ordinary Shares 0.00425%
22 March 2016 See row 1 above Acquisition on market by Fiduciary Trust
$3.66 per share 1,000 Ordinary Shares 0.00212%
24 March 2016 See row 1 above Acquisition on market by Fiduciary Trust $4.01 per share 16,400 Ordinary
Shares 0.03483%
24 March 2016 See row 1 above Acquisition on market by U.S. Trust
$4.01 per share 1,400 Ordinary Shares 0.00297%
For
per
sona
l use
onl
y
For
per
sona
l use
onl
y
For
per
sona
l use
onl
y
For
per
sona
l use
onl
y
For
per
sona
l use
onl
y
For
per
sona
l use
onl
y